It was originally indicated for only gluteal injection when approved by the FDA in February 2013.1,2 The approval of the deltoid injection site was based on two studies that evaluated the safety and ...

Seven out of ten hospital nurses who took part in a Canadian study used the dorsogluteal (DG) buttock site to administer intramuscular injections - despite the potential risks of sciatic nerve injury ...